Today IMUC ranks # as SELL CANDIDATE.
Today IMUC ranks # as SELL CANDIDATE.

IMUC stock ImmunoCellular Therapeutics Ltd

IMUC stock
ImmunoCellular Therapeutics Ltd

Wed 12'th Dec 2018

PERIOD 2018-09-13 - 2018-12-12
CHANGE -10.82%




Request Prediction

ImmunoCellular Therapeutics Ltd Stock Analysis

Technical stock analysis for Wed 12'th Dec 2018

Sell candidate since 2018-10-15 Loss -88.66%
Shorts 8.46% ( 2018-09-28 )
Cash n/a
Loans n/a
Beta 0.49
ROA -206.50

ImmunoCellular Therapeutics Ltd fell by -10.82% in the last day from $0.03 to $0.02 The price has fallen in 4 of the last 10 days and is down by -16.77% for this period. Volume has increased in the last day by 78 803 shares, but on falling prices. This may be an early warning and the risk will be increased slightly for the next couple of days. In total, 309 175 shares bought and sold for approximately $7 720.10.


ImmunoCellular Therapeutics Ltd lies the upper part of a very wide and falling trend in the short term, and this will normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $0.05 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -84.95% during the next 3 months and, with 90% probability hold a price between $-0.02 and $0.01 at the end of this period.

Click here for today's Top 5 Trending Companies


There are few to none technical positive signals at the moment. ImmunoCellular Therapeutics Ltd holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $0.03 and $0.03. A break-up above any of these levels will issue buy signals. A sales signal was issued from a pivot top point on Tuesday December 11, 2018, which indicates further falls until a new bottom pivot has been found. ImmunoCellular Therapeutics Ltd gained volume on the last day, but on falling prices. In technical terms this is called divergence and may be an early warning. In some cases increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-off's". The very low volume increases the risk and reduces the other technical signals issued.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSI14 is 30 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

ImmunoCellular Therapeutics Ltd finds support from accumulated volume at $0.02.

Support: $0.02 Price: $0.02 Resistance: $0.03


This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.01 between high and low, or 47.50%. For the last week, the stock has had a daily average volatility of 23.71%.

Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.

Overall risk:

Very Low Low Medium High Very High


ImmunoCellular Therapeutics Ltd holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our recommendation for this stock since last evaluation from a Sell Candidate to a Strong Sell Candidate.

Today IMUC ranks # as SELL CANDIDATE.
Today IMUC ranks # as SELL CANDIDATE.